Preclinical data on the SHP-01 lysin molecule was published in 2015 in the following study, authored by Rockefeller University scientists:
Wang Q, Euler CW, Delaune A, Fischetti VA. Using a Novel Lysin To Help Control Clostridium difficile Infections. Antimicrobial Agents & Chemotherapy. 2015 Dec;59(12):7447-57. PubMed Central PMCID: PMC4649177.
Clinical data on 19 patients treated using a novel oral formulation for transplanted bacteria were published in 2015 in a study authored by the company founders:
Hirsch BE, Saraiya N, Poeth K, Schwartz RM, Epstein ME, Honig G. Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium difficile infection. BMC Infect Dis. 2015 Apr 17;15:191. http://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-015-0930-z